Major breakthrough under EU Presidency
The Cyprus Presidency of the Council of the European Union has reached a preliminary agreement with the European Parliament on the Critical Medicines Act, following lengthy and intensive negotiations.
The agreement is described as one of the most important legislative files in European health policy.
The new framework aims to prevent and address shortages of essential medicines across the EU. It also seeks to strengthen pharmaceutical production within Europe and ensure patients in all member states have timely and equal access to necessary treatments.
According to the Cyprus Presidency, the deal represents a major step towards a more resilient European Health Union.
Joint procurement and stronger cooperation
A key provision of the Critical Medicines Act allows EU member states to join forces in the procurement of essential medicines.
This collective approach is expected to increase bargaining power, improve supply security, and secure better access conditions for critical treatments.
The regulation also promotes investment in European manufacturing of medicines and active pharmaceutical ingredients.
This is designed to reduce the EU’s dependence on a limited number of third countries and strengthen its strategic autonomy in the health sector.
Strong EU health policy milestone
The agreement is seen as a significant contribution to a safer and fairer European health system.
It reflects growing EU efforts to address vulnerabilities exposed by recent global supply chain disruptions.
The Cyprus Presidency said the outcome demonstrates its ability to play a key role in shaping EU policy through technical expertise and political coordination.
The deal is expected to leave a strong legacy in European health policy by improving access to essential medicines for all patients across the bloc.
Also read: 12 hospital staff quarantined after hantavirus protocol breach
For more videos and updates, check out our YouTube channel
